VIASYS Healthcare Inc. Medical Equipment Company Share Analysis

SUMMARY

Synergetics USA, Inc.Medical Equipment Company Share Analysis

Summary

This report is an essential source for data, analysis and strategic insight into Synergetics USA, Inc. The report provides key information relating to market share by sector and country, financial, SWOT and value chain analysis of the company. The report examines company's business structure and operations, history and products, and provides an analysis of its key revenue lines. It inspects the company's strategy, both in terms of its value chain positioning and strategic strengths and weaknesses.

Scope

• Revenues for the markets and sub-sectors Synergetics USA, Inc operates in by country and region.
• Detailed breakdowns of revenues and market share benchmarked against competitors.
• Profiles of the pipeline of products that the company is developing.
• Critical analysis of the company's strengths, weaknesses opportunities and threats and positioning on the value chain.
• Provides summary analysis of key revenue lines and strategy.
• Details on the company's history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions.
• Latest mergers and acquisitions, partnerships or financings of the company, including debt, equity or venture finance.

Reasons to buy

• A single source to fulfill all of your business and competitor intelligence needs
• Research your competitors business structure, strategy and prospects.
• Counter your competitors strengths and target their weaknesses.
• Identify your competitors key revenue streams by market and geography.
• Identify and assess potential corporate and investment opportunities
• Support sales activities by understanding your customers businesses better.
• Identify potential competitor products before they reach market.
• Qualify prospective partners and suppliers.

TABLE OF CONTENTS

1 Table of Contents 3
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 9
2.1 What Is This Report About? 9
3 Definitions of the Markets/Categories Covered 10
3.1 Surgical Equipment 10
3.1.1 Electrosurgical Devices 10
4 Company Snapshot 11
4.1 Key Information 11
4.2 Company Overview 11
4.3 Financial Performance 11
5 Business Description 12
5.1 Business Overview 12
5.2 Major Products and Services 13
5.2.1 Overview 13
6 History 15
7 SWOT Analysis 16
7.1 Overview 16
7.2 Synergetics USA, Inc. Strengths 16
7.2.1 R&D Activities 16
7.2.2 Constant Revenues 17
7.2.3 DualWave Technology 17
7.3 Synergetics USA, Inc. Weaknesses 17
7.3.1 Dependence on a Single Customer 17
7.3.2 Antitrust Lawsuit 17
7.4 Synergetics USA, Inc. Opportunities 17
7.4.1 Distribution Agreements 17
7.4.2 Product Launches 18
7.4.3 Triple Crown of Awards 18
7.5 Synergetics USA, Inc. Threats 18
7.5.1 Changes in the Health Care Industry 18
7.5.2 Electrical Safety Approval 19
7.5.3 Technological Changes 19
8 Competitors 20
9 Synergetics USA, Inc. Medical Equipment Market Share Analysis by Category 21
9.1 Synergetics USA, Inc., Surgical Equipment by Category, Global, Market share (2007) 21
9.2 Synergetics USA, Inc., Surgical Equipment by Category, North America, Market Share (2007) 21
10 Key Employees 22
11 Key Employee Biographies 23
12 Company Statement 24
13 Locations And Subsidiaries 27
13.1 Head Office 27
14 Financial Deals Landscape 28
14.1 Acquisition 28
14.1.1 Synergetics USA Acquires Medimold 28
14.1.2 Synergetics USA and Volk Optical Enters into Distribution Agreement 30
14.1.3 Synergetics and Quantel Medical Enters into Distribution Agreement 31
15 Recent Developments 34
15.1 Strategy and Business Planning 34
15.1.1 Mar 31, 2008: Synergetics to Close its Philadelphia Plant 34
15.2 Product Announcements 34
15.2.1 Oct 12, 2006 Synergetics USA Announces First Malis Advantage Shipments 34
15.2.2 Mar 31, 2006 Synergetics Releases Malis Advantage for Clinical Evaluation, Fourth Generation Electrosurgical Generator. 34
15.2.3 Oct 17, 2005 Synergetics USA, Inc. Unveils Malis Advantage at Congress of Neurological Surgeons 34
15.2.4 Jan 10, 2006: Synergetics Signs Distribution Agreement with Codman & Shurtleff 35
15.3 Financial Announcements 35
15.3.1 Jun 09, 2008: Synergetics Declares Q3 Fiscal 2008 Results 35
15.3.2 Mar 11, 2008: Synergetics Declares Q2 Fiscal 2008 Results 37
15.3.3 Feb 28, 2008: Synergetics to Declare Q2 Fiscal 2008 Results 39
15.3.4 Dec 10, 2007: Synergetics Reports Q1 Fiscal 2008 Results 39
15.3.5 Nov 21, 2007: Synergetics to Declare Q1 Fiscal 2008 Results 41
15.3.6 Oct 10, 2007: Synergetics Declares Q4 Fiscal 2007 Results 41
15.3.7 Jun 07, 2007: Synergetics Declares Q3 Fiscal 2007 Results 43
15.3.8 Mar 08, 2007: Synergetics Declares Q2 Fiscal 2007 Results 45
15.4 Other Significant Developments 47
15.4.1 Nov 09, 2007: Synergetics appoints New EVP, Sales and Marketing 47
15.4.2 Apr 10, 2007: Iridex Announces Settlement with Synergetics 47
16 Synergetics USA, Inc. Pipeline Products 48
16.1 Malis Advantage 48
16.1.1 Product Overview 48
16.1.2 Product Description 48
16.1.3 Product Status 48
16.1.4 Product Milestone 49
17 Appendix 50
17.1 Global Markets Direct Research Methodology 50
17.2 Coverage 51
17.3 Secondary Research 51
17.4 Primary Research 52
17.5 Models 52
17.6 Forecasts 53
17.7 Expert Panels 53
17.8 Market Revenue Chapters 53
17.8.1 Abbreviations 53
17.8.2 Currency Conversions 55
17.9 About Global Markets Direct 56
17.10 Contact Us 56
17.11 Disclaimer 56

1.1 List of Tables
Table 1: Synergetics USA, Inc., Key Facts 11
Table 2: Synergetics USA, Inc., SWOT Analysis 16
Table 3: Synergetics USA, Inc., Electrosurgical Devices by Geography, Global, Revenue ($ mn) and Market Share (%), 2007 21
Table 4: Synergetics USA, Inc., Electrosurgical Devices by Geography, North America, Revenue ($ mn) and Market Share (%), 2007 21
Table 5: Synergetics USA, Inc., Key Employees 22
Table 6: Abbreviations used in the Market Revenue Chapters 53
Table 7: Currency Conversion from USD to Local Currency at 2007 Constant Rate 55

1.2 List of Figures
Figure 1: Global Markets Direct Methodology 50